Beryllium: Genotoxicity and carcinogenicity

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 533, Issue 1-2, 2003, Pages 99-105

  Gordon, Terry ^a   Bowser, Darlene ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Beryllium; Carcinogenicity; Genotoxicity

Indexed keywords

BERYLLIUM;

CELL TRANSFORMATION; CHROMOSOME ABERRATION; DENSITY; GENETIC VARIABILITY; GENOTOXICITY; HUMAN; LUNG CARCINOGENESIS; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; TENSILE STRENGTH;

BACTERIA (MICROORGANISMS); MAMMALIA;

EID: 0344845182     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2003.08.022     Document Type: Review

References (53)

1. Skilleter D.N. Biochemical properties of beryllium potentially relevant to its carcinogenicity. Toxicol. Environ. Chem. 7:1984;213-228.
2. IARC (International Agency for Research on Cancer), IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 58, Beryllium, Cadmium, Mercury and Exposures in the Glass Manufacturing Industry, IARC, Lyon, 1993, pp. 41-117.
3. Deubner D.C., Lowney Y.W., Paustenbach D.J., Warmerdam J. Contribution of incidental exposure pathways to total beryllium exposures. Appl. Occup. Environ. Hyg. 16:2001;568-578. (Review).
4. American College of Chest Physicians, Beryllium disease: report of the section on nature and prevalence, Dis. Chest 48 (1965) 550-558.
5. Eisenbud M., Lisson J. Epidemiological aspects of beryllium-induced nonmalignant lung disease: a 30-year update. J. Occup. Med. 25:1983;196-202.
6. Finch G.L., Hoover M.D., Hahn F.F., Nikula K.J., Belinsky S.A., Haley P.J., Griffith W.C. Animal models of beryllium-induced lung disease. Environ. Health Perspect. 104S:1996;973-979.
7. EPA, Health Assessment Document for Beryllium, EPA Report No. 600/8-84-026F, Office of Research and Development, Research Triangle Park, NC, 1987.
8. B. McMahon, Assessment of human carcinogenicity, in: M.D. Rossman, O.P. Preuss, M.B. Powers (Eds.), Beryllium: Biomedical and Environmental Aspects, Williams & Wilkins, Baltimore, 1991, pp. 97-100.
9. IARC (International Agency for Research on Cancer), IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, vol. 23, Some Metals and Metallic Compounds, IARC, Lyon, 1980, pp. 143-204.
10. Mancuso T.F. Relation of duration of employment and prior respiratory illness to respiratory cancer among beryllium workers. Environ. Res. 3:1970;251-275.
11. T.F. Mancuso, Occupational lung cancer among beryllium workers, in: R. Lemen, J. Dement (Eds.), Dusts and Disease, Pathotox Publishers, Park Forest, IL, 1979, pp. 463-471.
12. Mancuso T.F. Mortality study of beryllium industry workers' occupational lung cancer. Environ. Res. 21:1980;48-55.
13. Mancuso T.F., El-Attar A.A. Epidemiological study of the beryllium industry: cohort methodology and mortality studies. J. Occup. Med. 11:1969;422-434.
14. D.L. Bayliss, W.S. Lainhart, L.J. Crally, et al., Mortality patterns in a group of former beryllium workers, in: Proceedings of the American Conference of Governmental Industrial Hygienists 33rd Annual Meeting, Toronto, Canada, 1971, pp. 94-107.
15. Wagoner J.K., Infante P.F., Bayliss D.L. Beryllium: an etiologic agent in the induction of lung cancer, nonneoplastic respiratory disease and heart disease among industrially exposed workers. Environ. Res. 21:1980;15-34.
16. Ward E., Okun A., Ruder A., Fingerhut M., Steenland K. A mortality study of workers at seven beryllium processing plants. Am. J. Ind. Med. 22:1992;885-904.
17. Steenland K., Ward E. Lung cancer incidence among patients with beryllium disease: a cohort mortality study. J. Natl. Cancer Inst. 83:1991;1380-1385.
18. Sanderson W.T., Ward E.M., Steenland K., Petersen M.R. Lung cancer case-control study of beryllium workers. Am. J. Ind. Med. 39:2001;133-144.
19. Infante P.F., Wagoner J.K., Sprince N.L. Mortality patterns from lung cancer and nonneoplastic respiratory disease among white males in the Beryllium Case Registry. Environ. Res. 21:1980;35-43.
20. Nickell-Brady C., Hahn F.F., Finch G.L., Belinsky S.A. Analysis of K. Carcinogenesis. 15:1994;257-262.
21. Schepers G.W.H., Durkan T.M., Delehant A.B., Creedon F.T. The biological action of inhaled beryllium sulfate: a preliminary chronic toxicity study in rats. Arch. Ind. Health. 15:1957;32-58.
22. Wagner W.D., Groth D.H., Holtz J.L., Madden G.E., Stokinger H.E. Comparative chronic inhalation toxicity of beryllium ores, bertrandite and beryl, with production of pulmonary tumors by beryl. Toxicol. Appl. Pharmacol. 15:1969;10-29.
23. Vorwald A.J., Reeves A.L. Pathologic changes induced by beryllium compounds. Arch. Ind. Health. 19:1959;190-199.
24. Reeves A.L., Deitch D., Vorwald A.J. Beryllium carcinogenesis. I. Inhalation exposure of rats to beryllium sulfate aerosol. Cancer Res. 27:1967;439-445.
25. A.J. Vorwald, The induction of experimental pulmonary cancer in the primate, in: R.J. Harris (Ed.), Proceedings of the IX International Cancer Congress, Tokyo, Springer, Berlin, 1967, p. 125 (Abstract I-07-e).
26. T. Kada, K. Hirano, Y. Shirasu, Screening of environmental chemical mutagens by the rec-assay system with Bacillus subtilis, in: F.J. de Serres, A. Hollaender (Eds.), Chemical Mutagens: Principles and Methods for Their Detection, vol. 6, Plenum Press, New York, 1980, pp. 149-173.
27. Kanamatsu N., Hara M., Kada T. Rec assay and mutagenicity studies on metal compounds. Mutat. Res. 77:1980;109-116.
28. Kuroda K., Endo G., Okamoto A., Yoo Y.S., Horiguchi S. Genotoxicity of beryllium, gallium and antimony in short-term assays. Mutat. Res. 264:1991;163-170.
29. Nishioka H. Mutagenic activities of metal compounds in bacteria. Mutat. Res. 31:1975;185-189.
30. Simmon V.F. In vitro assays for recombinogenic activity of chemical carcinogens and related compounds with Saccharomyces cerevisiae D3. J. Natl. Cancer Inst. 62:1979;901-909.
31. Rosenkranz H.S., Poirier L.A. Evaluation of the mutagenicity and DNA-modifying activity of carcinogens and noncarcinogens in microbial systems. J. Natl. Cancer Inst. 62:1979;873-892.
32. Simmon V.F. In vitro mutagenicity assays of chemical carcinogens and related compounds with Salmonella typhimurium. J. Natl. Cancer Inst. 63:1979;893-899.
33. Dunkel V.C., Zeiger E., Brusick D., McCoy E., McGregor D., Mortelmans K., Rosenkranz H.S., Simmon V.F. Reproducibility of microbial mutagenicity assays. I. Tests with Salmonella typhimurium and Escherichia coli using a standardized protocol. Environ. Mutat. 6:1984;1-254.
34. Ashby J., Ishidate M. Jr., Stoner G.D., Morgan M.A., Ratpan F., Callander R.D. Studies on the genotoxicity of beryllium sulphate in vitro and in vivo. Mutat. Res. 240:1990;217-225.
35. Ogawa H.I., Tsuruta S., Niyitani Y., Mino H., Sakata K., Kato Y. Mutagenicity of metal salts in combination with 9-amino-acridine in Salmonella tyhpimurium. Jpn. J. Genet. 62:1987;159-162.
36. Zakor R.A., Glickman B.W. Metal-induced mutagenesis in the IacI gene of Escherichia coli. Mutat. Res. 126(1):1984;9-18.
37. Rossman T.G., Molina M. The genetic toxicology of metal compounds. II. Enhancement of ultraviolet light-induced mutagenesis in Escherichia coli WP2. Environ. Mutat. 8:1986;263-271.
38. Miyaki M., Akamatsu N., Ono T., Koyama H. Mutagenicity of metal cations in cultured cells from Chinese hamster. Mutat. Res. 68(3):1979;259-263.
39. A.W. Hsie, N.P. Johnson, D.B. Couch, J.R. SanSebastian, J.P. O'Neill, J.D. Hoeschele, R.O. Rahn, N.L. Forbes, Quantiatative mammalian cell mutagenesis and a preliminary study of the mutagenic potential of metallic compounds, in: Trace Metals in Health and Disease, Raven, New York, 1979, pp. 55-69.
40. Hsie A.W.et al. Quantiatvie mammalina cell genetic toxicology. Envrion. Sci. Res. 15:1978;291-315.
41. Brooks A.L., Griffith W.C., Johnson N.F., Finch G.L., Cuddihy R.G. The induction of chromosome damage in CHO cells by beryllium and radiation given alone and in combination. Radiat. Res. 120:1989;494-507.
42. Larramendy M.L., Popescu N.C., DiPaolo J.A. Induction by inorganic metal salts of sister chromatid exchanges and chromosome aberrations in human and Syrian Hamster cell strains. Environ. Mutagen. 3:1981;597-606.
43. Anderson O. Effects of coal combustion products and metal compounds on sister chromatid exchange (SCE) in a macrophagelike cell line. Environ. Health Perspect. 47:1983;239-253.
44. DiPaolo J.A., Casto B.C. Quantitative studies of in vitro morphological transformation of Syrian hamster cells by inorganic metal salts. Cancer Res. 39:1979;1008-1013.
45. Casto B.C., Meyers J., DiPaolo J.A. Enhancement of viral transformation for evaluation of the carcinogenic or mutagenic potential of inorganic metal salts. Cancer Res. 39:1979;193-198.
46. Keshava N., Zhou G., Spruill M., Ensell M., Ong T.-M. Carcinogenic potential and genomic instability of beryllium sulphate in BALB/c-3T3 cells. Mol. Cell. Biochem. 222:2001;69-76.
47. Joseph P., Muchnok T., Ong T.-M. Gene expression profile in BALB/c-3T3 cells transformed with beryllium sulfate. Mol. Carcinogen. 32:2001;28-35.
48. Misra U.K., Gawdi G., Pizzo S.V. Beryllium fluoride-induced cell proliferation: a process requiring P21(ras)-dependent activated signal transduction and NF-kappaB-dependent gene regulation. J. Leukocyte Biol. 71:2002;487-494.
49. Skilleter D.N., Barrass N.C., Price R.J. C-myc expression is maintained during the G1 phase cell cycle block produced by beryllium. Cell Prolif. 24:1991;229-237.
50. Steele V.E., Wilkinson B.P., Arnold J.T., Kutzman R.S. Study of beryllium oxide genotoxicity in cultured respiratory epithelial cells. Inhal. Toxicol. 1:1989;95-110.
51. Nickell-Brady C., Hahn F.F., Finch G.L., Belinsky S.A. Analysis of K-ras, p53 and c-raf-1 mutations in beryllium-induced rat lung tumors. Carcinogenesis. 15:1994;257-262.
52. ink4a in primary rat lung tumors. Mol. Cell. Biol. 17:1997;1366-1374.
53. INK4a and estrogen receptor genes in rat lung tumors induced by particulate carcinogens. Carcinogenesis. 23:2002;335-339.